Adaptive Biotechnologies (ADPT) Misses Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $17.37 -0.91%
Revenue Growth %: +11.8%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.8%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.48), $0.18 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.78 million versus the consensus estimate of $48.45 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- Hermès can regain momentum despite China weakness, Jefferies says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
